Investment Management Corp of Ontario grew its holdings in The Allstate Co. (NYSE:ALL - Free Report) by 49.1% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,801 shares of the insurance provider's stock after purchasing an additional 2,900 shares during the period. Investment Management Corp of Ontario's holdings in Allstate were worth $1,669,000 as of its most recent SEC filing.
A number of other hedge funds also recently modified their holdings of the business. FSA Wealth Management LLC purchased a new stake in Allstate in the 3rd quarter worth about $26,000. Northwest Investment Counselors LLC acquired a new position in shares of Allstate in the 3rd quarter valued at about $28,000. Catalyst Capital Advisors LLC purchased a new stake in shares of Allstate in the third quarter worth approximately $29,000. Family Firm Inc. acquired a new stake in shares of Allstate during the second quarter worth approximately $38,000. Finally, MCF Advisors LLC boosted its holdings in shares of Allstate by 33.9% during the second quarter. MCF Advisors LLC now owns 332 shares of the insurance provider's stock worth $53,000 after purchasing an additional 84 shares during the period. Hedge funds and other institutional investors own 76.47% of the company's stock.
Allstate Stock Performance
Shares of NYSE ALL traded down $0.72 during trading hours on Thursday, hitting $204.23. 1,165,045 shares of the stock were exchanged, compared to its average volume of 1,549,566. The firm has a market capitalization of $54.08 billion, a P/E ratio of 13.23, a P/E/G ratio of 1.79 and a beta of 0.50. The Allstate Co. has a one year low of $134.17 and a one year high of $209.88. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40. The company's 50 day moving average is $194.09 and its 200 day moving average is $180.03.
Allstate (NYSE:ALL - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.20 by $1.71. The company had revenue of $16.63 billion during the quarter, compared to analysts' expectations of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The business's quarterly revenue was up 14.7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.81 earnings per share. On average, research analysts expect that The Allstate Co. will post 16.26 EPS for the current year.
Allstate Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th will be given a $0.92 dividend. This represents a $3.68 annualized dividend and a yield of 1.80%. The ex-dividend date is Friday, November 29th. Allstate's dividend payout ratio is currently 23.83%.
Insider Transactions at Allstate
In other Allstate news, insider John E. Dugenske sold 36,367 shares of the firm's stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the sale, the insider now directly owns 27,364 shares in the company, valued at $5,236,922.32. This trade represents a 57.06 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 1.80% of the company's stock.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on ALL shares. Wells Fargo & Company increased their target price on shares of Allstate from $175.00 to $186.00 and gave the stock an "equal weight" rating in a research report on Tuesday, November 5th. TD Cowen upped their price target on shares of Allstate from $193.00 to $224.00 and gave the stock a "buy" rating in a research note on Tuesday, September 3rd. Barclays lifted their price objective on Allstate from $175.00 to $187.00 and gave the company an "underweight" rating in a research report on Thursday, October 31st. The Goldman Sachs Group upped their target price on Allstate from $209.00 to $230.00 and gave the stock a "buy" rating in a research report on Friday, November 15th. Finally, Evercore ISI lifted their price target on Allstate from $191.00 to $195.00 and gave the company an "in-line" rating in a report on Wednesday, October 9th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $217.19.
Read Our Latest Analysis on ALL
Allstate Company Profile
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.